Rationale and design of HOMED-BP study: Hypertension Objective treatment based on Measurement by Electrical Devices of Blood Pressure study

Blood Pressure Monitoring

Volumn 7, Issue 1, 2002, Pages 77-82

  Fujiwara, Tohru ^a   Nishimura, Takuya ^a   Ohkuko, Takayoshi ^a   Imai, Yutaka ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Clinical trials; Hypertension; Self blood pressure monitoring

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTRICAL EQUIPMENT; ESSENTIAL HYPERTENSION; FOLLOW UP; HEART INFARCTION; HOME MONITORING; HUMAN; INTERNET; JAPAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SELF MONITORING; STROKE; TREATMENT OUTCOME; TREATMENT PLANNING; ARTICLE; CLINICAL PROTOCOL; EQUIPMENT DESIGN; HOME CARE; HYPERTENSION; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; TELEMEDICINE;

ADULT; AGED; BLOOD PRESSURE DETERMINATION; CLINICAL PROTOCOLS; EQUIPMENT DESIGN; HOME CARE SERVICES; HUMANS; HYPERTENSION; INTERNET; MIDDLE AGED; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; TELEMEDICINE;

EID: 0035992083     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126097-200202000-00016     Document Type: Conference Paper

References (26)

1. International Society of Hypertension guidelines for the management of hypertension
2. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trial
3. Efficacyofatenolol, and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
4. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
5. Blood pressure lowering treatment trialists' collaboration effects of ACE inhibitors calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomized trials
6. The reproducibility of average ambulatory, home, and clinic pressures
7. Reproducibility of home blood pressure measurements over a 1-year period
8. Randomized trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity - The Swedish Trial in Old Patients with Hypertension-2 study
9. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomised Trial (FACET) in patients with hypertension and NIDDM
10. African American Study of Kidney Disease and Hypertension (AASK) Study Group: Effects of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis
11. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomized trial - The Losartan Heart Failure Survival Study ELITE II
12. Renoprospective effect of the angiotensin-receptor anagonist irbesartan in patients with nephropathy due to type 2 diabetes
13. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
14. Primary prevention of renal failure in diabetic patients. The Bergamo Nephrologic Diabetes Complication Trial
15. The Varsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design
16. Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction. The OPTIMAAL trial design
17. Varsartan in acute myocardial infarction trial (VALIANT). Rationale and design
18. Proposal of reference values for home blood pressure measurement. Prognostic criteria based on a prospective observation of the general population in Ohasama, Japan
19. Device for self-blood pressure measurement which can monitor blood pressure during sleep
20. Home blood pressure measurements has a stronger predictive power for mortality than does screening blood pressure measurement: A population-based observation in Ohasama, Japan
21. Characteristics of a community based distribution of home blood pressure in Ohasama, a northern part of Japan
22. The British Hypertension Society Protocol for the evaluation of blood pressure measuring devices
23. Reference values for self-recorded blood pressure
24. The Sixth Report National High Blood Pressure Education Program, National Lung, and Blood Institute, National Institutes of Health